• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Caresyntax

Caresyntax Raises Additional $30M for Digital Surgery Platform

by Fred Pennic 09/16/2021 Leave a Comment

Caresyntax Raises Additional $30M for Digital Surgery Platform

- Caresyntax, a digital surgery platform, today announced a $30M extension to its Series C funding round included participation from BlackRock, ProAssurance, and Harmonix. In addition to existing investors such as the Relyens Group and IPF Partners. This extension brings the total Series C funding to $130M. - Caresyntax’s digital surgery platform uses proprietary software and artificial intelligence to analyze large volumes of real-world data in and around the operating room to deliver
Read More

Caresyntax Raises $100M to Expand Digital Surgery Platform in Key Markets

by Fred Pennic 04/28/2021 Leave a Comment

Caresyntax Raises $100M to Expand Digital Surgery Platform in Key Markets

What You Should Know: - Caresyntax, a Boston-based enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced that it has closed a significantly oversubscribed $100 million Series C funding round led by PFM Health Sciences LP, which also included participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital Partners, Arno Capital, Rezayat Investments, as well as current investors IPF Partners,
Read More

Caresyntax Lands $11.9M for EHR-Integrated Surgical Analytics Platform

by Jasmine Pennic 09/26/2017 Leave a Comment

Caresyntax

Caresyntax Inc., a Boston, MA-based surgical analytics and integration services company has raised $11.9 million in funding led by Norgine Ventures. The company plans to utilize the funding to establish its first full-time U.S. operations and headquarters in downtown Boston in October with plans to add more than 10 employees by the end of 2017.Partnering with GE, Medtronic and Siemens in the U.S., caresyntax is a sister company of Berlin-based S-CAPE GmbH, a global operating room integration
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |